Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Cesari

Showing results (1-10 of 606) with videos related to

Pageof 61
Sort By:
Expert Review of Clinical Pharmacology|September 28, 2020
How polypharmacy affects frailtyMatteo Cesari
Aging Clinical and Experimental Research|May 23, 2019
There is much more than just diseases that underlies frailty in older personsMatteo Cesari
Internal and Emergency Medicine|November 28, 2018
Why and how do we measure frailty?Matteo Cesari
Aging Medicine (Milton (N.S.W))|January 17, 2020
The frailty phenotype and sarcopenia: Similar but not the sameMatteo Cesari
Archives of Internal Medicine|January 12, 2011
The easiest way to predict adverse drug reactions in older personsMatteo Cesari
JAMA|January 6, 2011
Role of gait speed in the assessment of older patientsMatteo Cesari
Journal of the American Medical Directors Association|October 4, 2012
Perspective: Protein supplementation against sarcopenia and frailty: future perspectives from novel dataMatteo Cesari
Frontiers in Endocrinology|October 26, 2020
Obesity and COVID-19Domenico Azzolino, Matteo Cesari
Frontiers in Aging Neuroscience|August 1, 2014
Horse-racing effect and clinical trials in older personsMatteo Cesari, Marco Canevelli
Advances in Experimental Medicine and Biology|January 3, 2020
Frailty: What Is It?Marco Proietti, Matteo Cesari
Pageof 61

Showing results (1-10 of 606) with videos related to

Sort By:
Pageof 61
Expert Review of Clinical Pharmacology|September 28, 2020
How polypharmacy affects frailtyMatteo Cesari
Aging Clinical and Experimental Research|May 23, 2019
There is much more than just diseases that underlies frailty in older personsMatteo Cesari
Internal and Emergency Medicine|November 28, 2018
Why and how do we measure frailty?Matteo Cesari
Aging Medicine (Milton (N.S.W))|January 17, 2020
The frailty phenotype and sarcopenia: Similar but not the sameMatteo Cesari
Archives of Internal Medicine|January 12, 2011
The easiest way to predict adverse drug reactions in older personsMatteo Cesari
JAMA|January 6, 2011
Role of gait speed in the assessment of older patientsMatteo Cesari
Journal of the American Medical Directors Association|October 4, 2012
Perspective: Protein supplementation against sarcopenia and frailty: future perspectives from novel dataMatteo Cesari
Frontiers in Endocrinology|October 26, 2020
Obesity and COVID-19Domenico Azzolino, Matteo Cesari
Frontiers in Aging Neuroscience|August 1, 2014
Horse-racing effect and clinical trials in older personsMatteo Cesari, Marco Canevelli
Advances in Experimental Medicine and Biology|January 3, 2020
Frailty: What Is It?Marco Proietti, Matteo Cesari
Pageof 61